4//SEC Filing
Peterson Katharine 4
Accession 0000905148-25-000842
CIK 0001781174other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:36 PM ET
Size
5.2 KB
Accession
0000905148-25-000842
Insider Transaction Report
Form 4
Peterson Katharine
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+31,900→ 31,900 totalExercise: $5.31Exp: 2035-02-28→ Common Stock (31,900 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0002022214
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:36 PM ET
- Size
- 5.2 KB